Finn RS, Bengala C, Ibrahim N, Strauss LC, Fairchild J, Sy O, Roche H, Sparano J, Goldstein LJ
Phase II trial of dasatinib in triple-negative breast cancer: results of study CA 180059
Cancer Res. 2009;69(2):237S-237S.
Abstract